Clinical Investigator Advancement Award (CIVA)

Application is closed for 2025. For more information, look out for the next Call for Applications in early 2026.

A prestigious award that provides protected time of 0.2 FTE for 2 years for experienced CIVs to further develop their research focus. The CIV Advancement Award supports awardees in their journey to become recognised as independent established clinician researchers of international standing, supported by various grants, leading / co-leading research platforms, and contributing as active collaborators and academic clinician leaders in the AMC, ultimately translating research findings.Target: Supported CIVs who have plans to further grow their research platform / team / focusPrestigious awardFixed tenure of 2 years with possibility to renew once for 1 year No $$, just time (protected FTE of 0.2) Specific arrangement on how 0.2 FTE will be structured to suit type of research with HOD / ACP / Institution

Target: Supported CIVs who have plans to further grow their research platform / team / focus
Prestigious award
Fixed tenure of 2 years with possibility to renew once for 1 year
No $$, just time (protected FTE of 0.2)
Specific arrangement on how 0.2 FTE will be structured to suit type of research with HOD / ACP / Institution

Clear KPIs - should be greater than current research output and may include:
a. Larger grant support
b. Collaborations locally and internationally
c. Publications
d. Clinical trial participation
e. Specific research project

Each submission must be made using the prescribed forms:

CIV Advancement Award Application Form (to be completed by applicant)
Applicant CV & Career Development Plan (to be completed by applicant)
Nomination Form (to be completed and endorsed by Clinical HOD, ACP Chair and SDDC Head (where applicable)).

Applications that fail to comply with requirements in any of the templates and/or incomplete applications will be disqualified and will not be reviewed.

For applicants who are planning to apply for national level funding, are already holding national grants, or are supported by clinical trials with FTE allocation, please state the justification for the need of protected time in your application for the CIV Advancement Award.

For shortlisted applicants, a short interview with the review panel may be required. Details concerning the interview will be disseminated once it is finalised.

For successful applicants, the outcomes of the research programme / platform will be monitored during and after the award tenure. Applicants are expected to submit a Mid-term Progress Report and a Final Report with these outcomes periodically during and after the tenure of the award.

Please click here for more information and application materials.

For submission of applications or any enquiries, please contact Ms Veronica Yuen at vyuen@duke-nus.edu.sg.